Ticker,Title,Link
CYTK,Cytokinetics to Participate in September Investor Conferences,8/29/2024 10:00:00 PM
CYTK,Buy Rating Affirmed for Cytokinetics Amid Strong Cardiac Myosin Inhibitor Prospects and Positive Market Response,8/27/2024 11:45:20 AM
CYTK,BioMarin appoints new business chief and R&D head,8/21/2024 1:31:52 PM
CYTK,Wall Street Analysts Are Bullish on Top Healthcare Picks,8/13/2024 3:01:27 PM
CYTK,Cytokinetics’ Aficamten Poised for Market Success: A Strong Buy Recommendation,8/12/2024 8:55:31 PM
CYTK,Piper lists eight defensive biotechs to face market volatility,8/10/2024 6:29:35 PM
CYTK,Morgan Stanley Reaffirms Their Hold Rating on Cytokinetics (CYTK),8/9/2024 1:46:31 PM
CYTK,Cytokinetics Reports Second Quarter 2024 Financial Results,8/8/2024 10:00:00 PM
CYTK,Cytokinetics Q2 2024 Earnings Preview,8/7/2024 9:35:35 PM
CYTK,Piper Sandler Reaffirms Their Buy Rating on Cytokinetics (CYTK),8/5/2024 11:56:28 AM
CYTK,Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4),8/1/2024 10:00:00 PM
CYTK,Cytokinetics Announces Call for Proposals for Corporate Giving Program,7/30/2024 1:30:00 PM
CYTK,Robust CMI Drug Sales and Synergistic Commercial Strategies Bolster Buy Rating for Cytokinetics,7/26/2024 4:15:23 PM
CYTK,"Cytokinetics to Announce Second Quarter Results on August 8, 2024",7/25/2024 10:00:00 PM
CYTK,Cytokinetics Announces Seven Upcoming Presentations at  the European Society of Cardiology Congress 2024,7/16/2024 1:30:00 PM
CYTK,Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4),7/3/2024 10:00:00 PM
CYTK,7 Biotech Stocks to Boost Your Portfolio to Peak Health,6/26/2024 6:11:04 PM
CYTK,Buy Rating Affirmed: Cytokinetics’ Aficamten Shows Strong Commercial Promise in oHCM Treatment,6/24/2024 11:05:37 AM
CYTK,"Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM), Cytokinetics (CYTK) and Gossamer Bio (GOSS)",6/17/2024 3:05:40 PM
CYTK,Piper Sandler Sticks to Its Buy Rating for Cytokinetics (CYTK),6/10/2024 10:46:11 AM
CYTK,Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Agilon Health (AGL),6/6/2024 11:30:55 AM
CYTK,Cytokinetics says potential acquirer walked away,6/5/2024 2:28:20 PM
CYTK,Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),6/4/2024 10:00:00 PM
CYTK,Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK) and Canopy Growth (CGC),5/31/2024 2:40:30 PM
CYTK,Cytokinetics to Participate in June Investor Conferences,5/29/2024 10:00:00 PM
CYTK,Cytokinetics Announces Closing of Public Offering of Common Stock,5/28/2024 10:00:00 PM
CYTK,"Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo",5/25/2024 2:24:03 PM
CYTK,"Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Medtronic (MDT) and Cytokinetics (CYTK)",5/24/2024 9:50:14 AM
CYTK,"Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe",5/23/2024 8:30:41 PM
CYTK,Cytokinetics Announces Proposed Public Offering of Common Stock,5/22/2024 10:02:00 PM
CYTK,Cytokinetics CEO Blum says positioned to market heart drug aficamten by itself,5/17/2024 3:58:33 PM
CYTK,Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Alector (ALEC),5/16/2024 8:40:10 AM
CYTK,Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024,5/15/2024 1:30:00 PM
CYTK,Cytokinetics (CYTK) Gets a Hold from Bank of America Securities,5/14/2024 12:55:50 PM
CYTK,"Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)",5/13/2024 10:50:10 PM
CYTK,Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Cytokinetics (CYTK),5/10/2024 6:13:34 AM
CYTK,Cytokinetics: Strong Buy Rating on Promising Aficamten Prospects and Market Potential,5/9/2024 5:05:20 PM
CYTK,Cytokinetics Reports First Quarter 2024 Financial Results,5/8/2024 10:00:00 PM
CYTK,Cytokinetics to Hold Annual Meeting of Stockholders,5/7/2024 10:00:00 PM
CYTK,Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),5/2/2024 10:00:00 PM
CYTK,"Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Molina Healthcare (MOH) and Cytokinetics (CYTK)",4/30/2024 7:11:17 AM
CYTK,Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress,4/29/2024 10:00:00 PM
CYTK,Cytokinetics names Sung Lee as CFO,4/26/2024 8:32:49 PM
CYTK,"Cytokinetics to Announce First Quarter Results on May 8, 2024",4/24/2024 10:00:00 PM
CYTK,"Analysts’ Top Healthcare Picks: Cytokinetics (CYTK), Ultragenyx Pharmaceutical (RARE)",4/15/2024 10:10:52 AM
CYTK,Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress,4/10/2024 1:30:00 PM
CYTK,Understanding Serge Belanger’s Investment Rating: Key Influencing Factors,4/9/2024 10:06:10 AM
CYTK,Oppenheimer Remains a Buy on Cytokinetics (CYTK),4/8/2024 12:25:53 PM
CYTK,Buy Rating Affirmed on Cytokinetics Amid Promising Aficamten Clinical Results,4/5/2024 6:55:19 PM
CYTK,Cytokinetics (CYTK) Receives a Hold from Bank of America Securities,4/3/2024 1:05:19 PM
CYTK,Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),4/2/2024 10:00:00 PM
CYTK,Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference,4/1/2024 10:00:00 PM
CYTK,Cytokinetics gains amid renewed takeover speculation,3/26/2024 6:01:03 PM
CYTK,Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session,3/25/2024 1:15:04 PM
CYTK,7 Biotech Stocks Ready to Ride the Sector’s Resurgence,3/19/2024 12:01:33 AM
CYTK,"Analysts Conflicted on These Healthcare Names: Amedisys (AMED), Cytokinetics (CYTK) and Coherus Biosciences (CHRS)",3/14/2024 11:30:15 AM
CYTK,7 Biotech Stocks to Buy as Sector Rotation Ramps Up,3/13/2024 6:25:31 PM
CYTK,Cytokinetics drifts lower as CEO touts standalone strategy,3/11/2024 7:54:09 PM
CYTK,Truist Financial Gives a Buy Rating to Cytokinetics (CYTK),3/5/2024 12:25:51 PM
CYTK,Cytokinetics to Participate in March Investor Conferences,3/4/2024 10:00:00 PM
CYTK,Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),3/1/2024 10:00:00 PM
CYTK,Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day,2/29/2024 1:30:00 PM
CYTK,Buy Rating Affirmed for Cytokinetics Amidst Strong Clinical Progress and Strategic Growth Initiatives,2/28/2024 10:05:54 PM
CYTK,Cytokinetics Reports Fourth Quarter 2023 Financial Results,2/27/2024 10:00:00 PM
CYTK,Cytokinetics Q4 2023 Earnings Preview,2/26/2024 10:20:04 PM
CYTK,Novartis aiming to develop next-generation weight-loss drugs,2/16/2024 3:29:22 PM
CYTK,"Cytokinetics to Announce Fourth Quarter Results on February 27, 2024",2/13/2024 10:00:00 PM
CYTK,3 Biotech Stocks to Buy for the Next Bull Run: February 2024,2/8/2024 2:10:29 PM
CYTK,Cytokinetics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference,2/6/2024 10:00:00 PM
CYTK,"Cytokinetics weakness a buying opportunity, Truist says",2/5/2024 9:32:27 PM
CYTK,"CHEA, LESL and NUBI are among after hour movers",2/2/2024 10:07:29 PM
CYTK,Buy Rating on Cytokinetics: Aficamten’s Market Potential and Clinical Advantages Reinforce Positive Outlook,2/1/2024 6:15:45 PM
CYTK,Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program,1/29/2024 1:30:00 PM
CYTK,3 Healthcare Stocks at 52-Week Lows: Buy or Bye?,1/26/2024 5:01:25 PM
CYTK,Aficamten’s Promising Future in oHCM Treatment Bolsters Buy Rating,1/25/2024 4:16:13 PM
CYTK,"UBS cuts Cytokinetics to neutral, sees takeout valuation at $105",1/24/2024 2:36:36 PM
CYTK,Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024 ,1/18/2024 7:00:00 PM
CYTK,"Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Blueprint Medicines (BPMC)",1/17/2024 9:51:01 AM
CYTK,"Analysts Offer Insights on Healthcare Companies: Santhera Pharmaceuticals Holding (OtherSPHDF), Ironwood Pharma (IRWD) and Cytokinetics (CYTK)",1/12/2024 11:20:17 AM
CYTK,Cytokinetics Stock Tanks 14% ,1/11/2024 5:44:56 PM
CYTK,Strategic Growth and Acquisition Potential Underpin Buy Rating for Cytokinetics (CYTK),1/9/2024 6:15:24 AM
CYTK,Strong Buy on Cytokinetics: Aficamten’s Market Potential and First-Line Treatment Prospects Drive Price Target Increase,1/5/2024 6:55:29 PM
CYTK,7 Stocks Primed for a Spectacular Comeback in 2024,1/3/2024 11:17:42 PM
CYTK,Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference,1/2/2024 10:00:00 PM
CYTK,"Analysts’ Top Healthcare Picks: NeoGenomics (NEO), Cytokinetics (CYTK)",1/1/2024 7:40:25 AM
CYTK,Cytokinetics' Drug Potential: Analyst Suggests Key Role Of Established Pharma For Potential Launch,12/28/2023 6:19:47 PM
CYTK,Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher,12/27/2023 8:19:32 PM
CYTK,"Cytokinetics to Host Investor Call on December 27 to Discuss the Topline Results from SEQUOIA-HCM, the Pivotal Phase 3 Clinical Trial of Aficamten in Patients with Obstructive Hypertrophic...",12/26/2023 10:00:11 PM
CYTK,Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session,12/21/2023 7:01:45 PM
CYTK,Analysts Conflicted on These Healthcare Names: Outlook Therapeutics (OTLK) and Cytokinetics (CYTK),12/20/2023 11:10:07 AM
CYTK,Buy Rating Affirmed: Steady Prescription Growth and Positive Expert Insights for Cytokinetics’s Camzyos,12/19/2023 7:35:49 AM
CYTK,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cytokinetics (CYTK), Walgreens Boots Alliance (WBA) and Humana (HUM)",12/13/2023 9:40:47 AM
CYTK,"Analysts Offer Insights on Healthcare Companies: Allakos (ALLK), Cytokinetics (CYTK) and InMode (INMD)",12/8/2023 1:10:20 PM
CYTK,Cytokinetics Presents Results From COURAGE-ALS at the 34th International Symposium on ALS/MND,12/7/2023 1:30:00 PM
CYTK,Wall Street Analysts Are Bullish on Top Healthcare Picks,12/6/2023 1:30:22 PM
CYTK,"Analysts Are Bullish on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Cooper Co (COO)",12/5/2023 12:32:44 PM
CYTK,Buy Rating on Cytokinetics: Upcoming Catalysts and Long-Term Commercial Prospects,12/4/2023 3:15:22 AM
CYTK,Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),12/1/2023 10:00:00 PM
CYTK,Cytokinetics Announces Five Presentations at the 34th International Symposium on ALS/MND,11/29/2023 10:00:00 PM
CYTK,"Analysts Offer Insights on Healthcare Companies: Agilent (A), Cytokinetics (CYTK) and Aligos Therapeutics (ALGS)",11/22/2023 11:40:41 AM
CYTK,Prospective Growth for Cytokinetics: A Comprehensive Analysis of Aficamten’s Potential and Market Impact,11/16/2023 12:18:26 PM
CYTK,Goldman Sachs Says These 2 Healthcare Stocks Look Attractive — Here’s What Makes Them Each a ‘Buy’ Right Now,11/10/2023 8:04:00 PM
CYTK,Anticipated SEQUOIA-HCM Study Results Influence Salim Syed’s Buy Rating for Cytokinetics,11/9/2023 7:08:23 PM
CYTK,"Analysts’ Top Healthcare Picks: Lantheus (LNTH), Cytokinetics (CYTK)",11/7/2023 2:40:18 AM
CYTK,"Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Celldex (CLDX) and Cytokinetics (CYTK)",11/6/2023 1:01:52 PM
CYTK,Piper Sandler Sticks to Its Buy Rating for Cytokinetics (CYTK),11/3/2023 10:41:52 AM
CYTK,Buy Rating for Cytokinetics Fueled by Potential M&A Interest and Post-Patent Strategic Positioning Opportunities,11/2/2023 5:51:25 AM
CYTK,What Wall Street expects from Cytokinetics's earnings,11/1/2023 3:01:13 PM
CYTK,"Analysts Are Bullish on Top Healthcare Stocks: Cytokinetics (CYTK), Axsome Therapeutics (AXSM)",10/31/2023 6:40:29 AM
CYTK,"Analysts Offer Insights on Healthcare Companies: G1 Therapeutics (GTHX), Coherus Biosciences (CHRS) and Cytokinetics (CYTK)",10/30/2023 10:20:18 AM
CYTK,Morgan Stanley Predicts at Least 70% Upside for These 2 High-Conviction Stocks — They Have Upcoming Catalysts and Strong Growth Prospects,10/27/2023 1:08:26 AM
CYTK,HC Wainwright & Co. Maintains Buy Rating for Cytokinetics: Here's What You Need To Know,10/20/2023 7:00:22 PM
CYTK,Buy Rating for Cytokinetics’ Stock: Analyzing Trends in Camzyos Prescription Dosage and Potential Market Growth,10/17/2023 4:56:48 AM
CYTK,"Analysts’ Top Healthcare Picks: Cytokinetics (CYTK), Axsome Therapeutics (AXSM)",10/11/2023 6:21:18 AM
CYTK,Expert Ratings for Cytokinetics,10/9/2023 5:00:19 PM
CYTK,Why CalAmp Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session,10/6/2023 7:59:09 PM
CYTK,Rising Prescription Rates and Market Shifts: A Positive Outlook for Cytokinetics,10/3/2023 6:35:38 AM
CYTK,"Analysts’ Top Healthcare Picks: Axsome Therapeutics (AXSM), Cytokinetics (CYTK)",9/27/2023 6:32:10 AM
CYTK,"Analysts’ Top Healthcare Picks: Cytokinetics (CYTK), Amgen (AMGN)",9/25/2023 11:00:34 AM
CYTK,Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and CymaBay Therapeutics (CBAY),9/22/2023 10:31:47 AM
CYTK,"Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Alnylam Pharma (ALNY)",9/14/2023 10:50:11 AM
CYTK,Mizuho Securities Remains a Buy on Cytokinetics (CYTK),9/12/2023 3:35:33 PM
CYTK,The 3 Best Mid-Cap Stocks to Buy Now: September 2023,9/7/2023 8:29:02 PM
CYTK,H.C. Wainwright Keeps Their Buy Rating on Cytokinetics (CYTK),9/6/2023 2:06:17 PM
CYTK,"Analysts’ Top Healthcare Picks: Arcutis Biotherapeutics (ARQT), Cytokinetics (CYTK)",8/25/2023 12:10:13 PM
CYTK,Where Cytokinetics Stands With Analysts,8/22/2023 4:00:37 PM
CYTK,Mizuho Securities Keeps Their Buy Rating on Cytokinetics (CYTK),8/18/2023 11:55:06 AM
CYTK,"Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023",8/15/2023 5:00:34 PM
CYTK,Analysts Offer Insights on Healthcare Companies: Durect (DRRX) and Cytokinetics (CYTK),8/11/2023 12:01:04 PM
CYTK,Truist Financial Sticks to Their Buy Rating for Cytokinetics (CYTK),8/7/2023 2:26:38 AM
CYTK,Where Cytokinetics Stands With Analysts,8/4/2023 11:00:24 PM
CYTK,Mizuho Securities Sticks to Its Buy Rating for Cytokinetics (CYTK),8/3/2023 11:25:13 PM
CYTK,Here's what Wall Street expects from Cytokinetics's earnings,8/2/2023 3:01:13 PM
CYTK,Cytokinetics (CYTK) Receives a Buy from Mizuho Securities,7/28/2023 8:05:09 PM
CYTK,"Analysts Are Bullish on These Healthcare Stocks: Cidara Therapeutics (CDTX), Cytokinetics (CYTK)",7/21/2023 12:40:51 PM
CYTK,Wall Street Analysts Are Bullish on Top Healthcare Picks,7/14/2023 12:00:48 PM
CYTK,Mizuho Securities Sticks to Their Buy Rating for Cytokinetics (CYTK),7/7/2023 12:45:31 PM
CYTK,Mizuho Securities Remains a Buy on Cytokinetics (CYTK),6/30/2023 12:05:08 PM
CYTK,Piper Sandler Remains a Buy on Cytokinetics (CYTK),6/26/2023 12:06:33 PM
CYTK,Mizuho Securities Keeps Their Buy Rating on Cytokinetics (CYTK),6/23/2023 12:05:12 PM
CYTK,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Seagen (SGEN), Verve Therapeutics (VERV) and Cytokinetics (CYTK)",6/22/2023 11:10:12 AM
CYTK,5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies,6/20/2023 11:14:33 PM
CYTK,Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Stereotaxis (STXS),6/16/2023 1:30:28 PM
CYTK,Mizuho Securities Sticks to Their Buy Rating for Cytokinetics (CYTK),6/9/2023 12:05:07 PM
CYTK,Mizuho Securities Remains a Buy on Cytokinetics (CYTK),6/2/2023 11:55:06 AM
CYTK,Cytokinetics (CYTK) Gets a Buy from Mizuho Securities,5/26/2023 11:35:11 AM
CYTK,What 20 Analyst Ratings Have To Say About Cytokinetics,5/22/2023 9:01:56 PM
CYTK,Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytokinetics (CYTK) and Pfizer (PFE),5/19/2023 12:10:10 PM
CYTK,Oppenheimer Sticks to Their Buy Rating for Cytokinetics (CYTK),5/16/2023 4:25:22 PM
CYTK,"Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Harrow Health (HROW)",5/12/2023 11:50:07 AM
CYTK,Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Siemens Healthineers AG (OtherSEMHF),5/11/2023 1:20:37 PM
CYTK,18 Analysts Have This to Say About Cytokinetics,5/5/2023 5:00:33 PM
CYTK,"Cytokinetics GAAP EPS of -$1.38 misses by $0.17, revenue of $4.61M beats by $2.11M",5/4/2023 8:03:47 PM
CYTK,Cytokinetics earnings: here's what Wall Street expects,5/3/2023 3:01:13 PM
CYTK,Cytokinetics (CYTK) Gets a Buy from Piper Sandler,5/2/2023 11:25:26 AM
CYTK,"Analysts’ Top Healthcare Picks: Cytokinetics (CYTK), Axsome Therapeutics (AXSM)",4/28/2023 1:30:25 PM
CYTK,What is behind biotech M&A resurgence?,4/23/2023 4:00:00 PM
CYTK,Mizuho Securities Keeps Their Buy Rating on Cytokinetics (CYTK),4/21/2023 12:06:04 PM
CYTK,Analyst Ratings for Cytokinetics,4/18/2023 10:01:56 PM
CYTK,"Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Tonix Pharma (TNXP) and Viewray (VRAY)",4/14/2023 12:30:22 PM
CYTK,Mizuho Securities Sticks to Its Buy Rating for Cytokinetics (CYTK),4/7/2023 1:45:17 PM
CYTK,"3 Best Stocks to Buy Now, 4/3/2023, According to Top Analysts",4/3/2023 12:47:15 PM
CYTK,Bank of America Securities Reaffirms Their Hold Rating on Cytokinetics (CYTK),4/1/2023 12:55:08 PM
CYTK,Analyst Expectations for Cytokinetics's Future,3/31/2023 10:01:23 PM
CYTK,Mizuho Securities Remains a Buy on Cytokinetics (CYTK),3/24/2023 12:35:17 PM
CYTK,Mizuho Securities Sticks to Their Buy Rating for Cytokinetics (CYTK),3/17/2023 4:55:07 PM
CYTK,"Analysts Are Bullish on Top Healthcare Stocks: Cytokinetics (CYTK), Aldeyra Therapeutics (ALDX)",3/10/2023 1:10:22 PM
CYTK,Cantor Fitzgerald Sticks to Their Buy Rating for Cytokinetics (CYTK),3/7/2023 4:25:16 PM
CYTK,Analyst Ratings for Cytokinetics,3/6/2023 5:00:52 PM
CYTK,"Pre-market Movers: MTC, SI, FNKO, OKTA, AEHR… ",3/2/2023 1:27:00 PM
CYTK,"Cytokinetics GAAP EPS of -$1.45 misses by $0.24, revenue of $1.96M misses by $4.5M",3/1/2023 9:00:51 PM
CYTK,Cytokinetics receives FDA Complete Response Letter for omecamtiv mecarbil; down 8%,2/28/2023 11:31:23 PM
CYTK,"Catalyst watch: Tesla event, Microsoft talks OpenAI, Rivian earnings and Chevron",2/24/2023 7:00:00 PM
CYTK,"Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2023",2/17/2023 4:01:36 PM
CYTK,Mizuho Securities Keeps Their Buy Rating on Cytokinetics (CYTK),2/10/2023 12:55:05 PM
CYTK,Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Roche Holding AG (OtherRHHVF),2/3/2023 1:20:04 PM
CYTK,"February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More",1/31/2023 8:33:01 PM
CYTK,Biotech Stocks Facing FDA Decision In February 2023 ,1/29/2023 12:18:56 PM
CYTK,"Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Siemens Healthineers AG (SEMHF)",1/27/2023 1:01:13 PM
CYTK,"Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Cytokinetics (CYTK) and Legend Biotech (LEGN)",1/20/2023 1:20:25 PM
CYTK,Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Maravai Lifesciences Holdings (MRVI),1/17/2023 4:32:11 PM
CYTK,Mizuho Securities Sticks to Their Buy Rating for Cytokinetics (CYTK),1/13/2023 5:35:05 PM
CYTK,Mizuho Securities Remains a Buy on Cytokinetics (CYTK),1/5/2023 12:15:11 AM
CYTK,Analysts Line up Their Top Picks for 2023,1/2/2023 9:29:57 AM
CYTK,Mizuho Securities Keeps Their Buy Rating on Cytokinetics (CYTK),12/30/2022 12:45:27 PM
CYTK,"Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors",12/27/2022 3:11:57 PM
CYTK,Tesla To $175? Here Are 10 Other Price Target Changes For Friday,12/23/2022 3:21:55 PM
CYTK,Analyst Ratings for Cytokinetics,12/20/2022 9:03:18 PM
CYTK,Goldman Sachs Keeps Their Buy Rating on Cytokinetics (CYTK),12/15/2022 4:26:51 PM
CYTK,Why Netcapital Shares Are Trading Lower By Over 33%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session,12/14/2022 8:12:59 PM
CYTK,Cytokinetics faces setback as FDA advisory panel fails to endorse heart failure drug,12/13/2022 10:15:21 PM
CYTK,"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Cytokinetics (CYTK) and Legend Biotech (LEGN)",12/12/2022 2:01:23 PM
CYTK,"Catalyst Watch: FOMC, CPI print and spotlight on Yum Brands",12/9/2022 7:30:48 PM
CYTK,H.C. Wainwright Keeps Their Buy Rating on Cytokinetics (CYTK),12/7/2022 3:25:50 PM
CYTK,Mizuho Securities Reaffirms Their Buy Rating on Cytokinetics (CYTK),12/2/2022 1:15:33 PM
CYTK,Biotech Stocks Facing FDA Decision In December 2022 ,11/28/2022 6:38:51 AM
CYTK,Mizuho Securities Remains a Buy on Cytokinetics (CYTK),11/25/2022 2:45:11 PM
CYTK,Cytokinetics (CYTK) Receives a Buy from Mizuho Securities,11/18/2022 12:45:13 PM
CYTK,Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Senti Biosciences (SNTI),11/11/2022 1:00:56 PM
CYTK,"Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), AxoGen (AXGN)",11/9/2022 5:30:24 AM
CYTK,"PRVB Awaits FDA's Decision, BCAB Soars On Clinical Trial Updates, CYTK Braces For Busy Months ",11/4/2022 12:29:19 PM
CYTK,"Cytokinetics GAAP EPS of -$1.52 misses by $0.35, revenue of $2.5M misses by $0.73M",11/3/2022 8:44:38 PM
CYTK,Cytokinetics earnings: here's what Wall Street expects,11/2/2022 3:01:13 PM
CYTK,Cytokinetics (CYTK) Receives a Buy from Mizuho Securities,10/26/2022 1:35:27 PM
CYTK,Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK) and Arcutis Biotherapeutics (ARQT),10/14/2022 12:01:28 PM
CYTK,"Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022",10/11/2022 4:06:25 PM
CYTK,Cytokinetics gets monitoring panel's nod to continue phase 3 trial of ALS drug reldesemtiv,10/10/2022 12:28:54 PM
CYTK,Coca-Cola Price Target Cut By This Analyst? Plus Rocket Pharmaceuticals Likely To Rally Around 306%,10/3/2022 2:48:01 PM
CYTK,Mizuho Securities Sticks to Their Buy Rating for Cytokinetics (CYTK),9/30/2022 8:06:40 PM
CYTK,Mizuho Securities Reaffirms Their Buy Rating on Cytokinetics (CYTK),9/23/2022 12:15:09 PM
CYTK,Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday,9/7/2022 11:16:07 AM
CYTK,"iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday",8/8/2022 11:13:41 AM
CYTK,What 5 Analyst Ratings Have To Say About Cytokinetics,8/5/2022 3:50:38 PM
CYTK,"Cytokinetics GAAP EPS of -$0.23 beats by $0.81, revenue of $88.97M beats by $85.24M",8/4/2022 8:13:15 PM
CYTK,Cytokinetics is about to announce its earnings — here's what to expect,8/3/2022 3:01:13 PM
CYTK,Analyst Ratings for Cytokinetics,7/15/2022 7:17:39 PM
CYTK,Cytokinetics prices $450M of convertible debt offering,7/1/2022 8:00:27 AM
CYTK,Cytokinetics Declines 8% Following $450 Mln Notes Offering ,6/30/2022 3:53:40 PM
CYTK,"LXRX, ADAG, HYPR and CYTK among after hour movers",6/29/2022 9:25:10 PM
CYTK,Cytokinetics announces upcoming FDA AdCom meeting on heart failure therapy,6/24/2022 1:18:38 PM
CYTK,Cytokinetics announces extension of FDA review period for heart failure therapy,6/17/2022 12:09:23 PM
CYTK,What 5 Analyst Ratings Have To Say About Cytokinetics,6/10/2022 7:11:25 PM
CYTK,Where Cytokinetics Stands With Analysts,5/24/2022 3:01:47 PM
CYTK,Cytokinetics touts long-term benefit of cardiomyopathy drug aficamten,5/23/2022 4:15:25 PM
CYTK,"The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More",5/22/2022 9:58:01 PM
CYTK,"The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation",5/17/2022 3:04:56 PM
CYTK,Cytokinetics rallies after Mizuho raises price target to $80,5/16/2022 3:46:02 PM
CYTK,"RGNX, FATE and ALVR are among after hours",5/6/2022 9:50:34 PM
CYTK,"Cytokinetics GAAP EPS of -$1.05 misses by $0.10, revenue of $1.15M misses by $3.57M",5/4/2022 8:02:54 PM
CYTK,Cytokinetics Q1 2022 Earnings Preview,5/3/2022 9:35:51 PM
CYTK,70 Biggest Movers From Friday,5/2/2022 11:46:47 AM
CYTK,48 Stocks Moving In Friday's Mid-Day Session,4/29/2022 6:27:17 PM
CYTK,"The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck  Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More",3/27/2022 10:40:40 PM
CYTK,"Cytokinetics GAAP EPS of -$0.36 beats by $0.51, revenue of $55.6M beats by $50.04M; initiates FY22 guidance",2/24/2022 9:30:43 PM
CYTK,Notable earnings after Thursday's close,2/23/2022 10:35:44 PM
CYTK,Cytokinetics announces 3-year collaboration with American Heart Association Bay Area,2/16/2022 12:41:49 PM
CYTK,Cytokinetics’ marketing application for heart failure therapy goes under FDA review,2/4/2022 2:29:56 PM
CYTK,Cytokinetics reports inducement grants,2/1/2022 10:12:03 PM
CYTK,56 Biggest Movers From Friday,1/10/2022 10:47:25 AM
CYTK,33 Stocks Moving In Friday's Mid-Day Session,1/7/2022 6:12:32 PM
CYTK,"Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021",12/22/2021 4:07:27 PM
CYTK,What 5 Analyst Ratings Have To Say About Cytokinetics,12/10/2021 7:22:37 PM
CYTK,Cytokinetics wins FDA’s Breakthrough Therapy tag for heart disease candidate,12/9/2021 1:04:27 PM
CYTK,"The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré",12/7/2021 2:18:13 PM
CYTK,"The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More",12/6/2021 12:07:24 PM
CYTK,"Cytokinetics EPS misses by $0.19, misses on revenue",11/3/2021 8:03:07 PM
CYTK,Cytokinetics Q3 2021 Earnings Preview,11/2/2021 9:35:35 PM
CYTK,"The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs",10/8/2021 1:31:18 PM
CYTK,"Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021",10/7/2021 4:02:38 PM
CYTK,"The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal",10/6/2021 1:33:33 PM
CYTK,"The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout",10/5/2021 2:01:45 PM
CYTK,"The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO",10/1/2021 1:56:15 PM
CYTK,"The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive",9/28/2021 2:18:52 PM
CYTK,"The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold",9/17/2021 1:36:08 PM
CYTK,"The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical",8/31/2021 2:06:37 PM
CYTK,"The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts",8/10/2021 1:55:36 PM
CYTK,"Cytokinetics EPS misses by $0.20, misses on revenue",8/5/2021 8:12:21 PM
CYTK,Here's what to expect from Cytokinetics's earnings report,8/3/2021 3:02:13 PM
CYTK,Cytokinetics opens enrollment for late-stage reldesemtiv ALS study,8/2/2021 11:58:14 AM
CYTK,"NRx Pharma, Cassava Sciences lead weekly healthcare gainers; Seres Therapeutics trail",7/25/2021 12:28:19 AM
CYTK,Cytokinetics prices stock offering at $27.50/share,7/21/2021 10:26:42 AM
CYTK,Why Cytokinetics (CYTK) Shares Are Trading Higher Today?,7/20/2021 8:21:09 PM
CYTK,Mid-Afternoon Market Update: Dow Tumbles 850 Points; Aehr Test Systems Shares Surge,7/19/2021 8:34:26 PM
CYTK,Cytokinetics completes enrollment in late-stage heart disease trial,6/15/2021 11:53:58 AM
CYTK,Cytokinetics and ALS association renew partnership,5/19/2021 11:58:27 AM
CYTK,Cytokinetics Post-Hoc Data Suggests Omecamtiv Mecarbil Works Better In High-Risk Patients For Heart Failure,5/17/2021 7:02:01 PM
CYTK,"Cytokinetics EPS misses by $0.06, misses on revenue",5/6/2021 8:02:57 PM
CYTK,Here's what Wall Street expects from Cytokinetics's earnings report,5/4/2021 3:02:12 PM
CYTK,Astellas Walks Away From $450M Research & Discovery Partnership With Cytokinetics,5/3/2021 8:48:47 PM
CYTK,"Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge",5/1/2021 7:19:25 PM
CYTK,"The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants",2/25/2021 2:08:03 PM
CYTK,Here's what to expect from Cytokinetics's earnings,2/23/2021 3:01:52 PM
CYTK,"The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings",2/20/2021 3:36:28 PM
CYTK,Barclays initiates Cytokinetics with an outperform rating,2/18/2021 7:55:17 PM
CYTK,Cytokinetics Announces First Patient Dosed in Cohort 2 of Redwood-HCM,1/13/2021 1:30:00 PM
CYTK,Cytokinetics: CK-274 Receives Orphan Drug Designation - Quick Facts ,1/11/2021 1:54:58 PM
CYTK,Cytokinetics to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference,1/6/2021 10:00:00 PM
CYTK,Cytokinetics Regains European Rights to Omecamtiv Mecarbil,12/23/2020 1:30:00 PM
CYTK,Cytokinetics Announces Data and Trial Design Presented at the International Symposium on ALS/MND,12/14/2020 1:30:00 PM
CYTK,Cytokinetics Announces Progression of REDWOOD-HCM to Cohort 2,12/9/2020 1:30:00 PM
CYTK,Cytokinetics Announces Additional Results From GALACTIC-HF Presented at the 17th Global Cardiovascular Clinical Trialists,12/7/2020 1:30:00 PM
CYTK,Cytokinetics Announces Three Presentations at the International Symposium on ALS/MND,12/3/2020 1:30:00 PM
CYTK,Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4),12/1/2020 10:00:00 PM
CYTK,Cytokinetics to Participate in Upcoming Investor Conferences,11/24/2020 10:00:00 PM
CYTK,Amgen Terminates Collaboration With Cytokinetics On Omecamtiv Mecarbil And AMG 594 ,11/23/2020 2:37:01 PM
CYTK,Cytokinetics Names Nancy Wysenski to Board of Directors,11/20/2020 1:30:00 PM
CYTK,Cytokinetics Announces Preclinical Data for CK-3773274 and CK-3772271 Presented at the AHA Scientific Sessions 2020 ,11/16/2020 1:30:00 PM
CYTK,Cytokinetics (-7%) on omecamtiv mecarbil data from late-stage heart failure study,11/13/2020 7:31:17 PM
CYTK,Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),11/10/2020 10:00:00 PM
CYTK,Cytokinetics Announces Six Presentations Related to Heart Failure and Hypertrophic Cardiomyopathy at the AHA Scientific Sessions 2020,11/6/2020 1:30:00 PM
CYTK,Cytokinetics Reports Third Quarter 2020 Financial Results,11/4/2020 10:00:00 PM
CYTK,"Cytokinetics to Announce Third Quarter Results on November 4, 2020",10/21/2020 10:00:10 PM
CYTK,"Pre-market Movers In Healthcare Sector: MDRX, TLC, HGEN, ENLV, BNTX, ATEC... ",10/14/2020 12:46:03 PM
CYTK,"JMIA, EV, CYTK and WWR among midday movers",10/8/2020 4:41:35 PM
CYTK,Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),10/5/2020 10:00:10 PM
CYTK,Cytokinetics Announces Publication of Manuscript Detailing Baseline Characteristics of GALACTIC-HF in European Journal of Heart Failure,10/2/2020 1:30:10 PM
CYTK,Cytokinetics Announces Data to Be Presented at the HFSA Virtual Annual Scientific Meeting 2020,9/24/2020 10:00:10 PM
CYTK,Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3772271,9/23/2020 1:30:10 PM
CYTK,Cytokinetics Announces GALACTIC-HF Accepted for Presentation In Late Breaking Clinical Trial Session At American Heart Association Scientific Sessions,9/17/2020 1:30:10 PM
CYTK,Cytokinetics to Participate in Upcoming Investor Conferences,9/2/2020 10:00:10 PM
CYTK,Cytokinetics and Cure SMA Renew Partnership to Advance Education and Awareness of SMA,8/26/2020 1:30:10 PM
CYTK,Cytokinetics Announces Partnership to Improve Prediction of Risk and Outcomes in Hypertrophic Cardiomyopathy,8/18/2020 1:30:10 PM
CYTK,Cytokinetics Reports Second Quarter 2020 Financial Results,8/6/2020 10:00:10 PM
CYTK,Here's what Wall Street expects from Cytokinetics's earnings report,8/5/2020 3:04:13 PM
CYTK,"Cytokinetics to Announce Second Quarter Results on August 6, 2020",7/23/2020 10:00:10 PM
CYTK,Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares,7/21/2020 10:00:10 PM
CYTK,Cytokinetics Announces Pricing of Public Offering of Common Stock,7/17/2020 5:32:12 AM
CYTK,Cytokinetics Announces Proposed Public Offering of Common Stock,7/15/2020 10:00:10 PM
CYTK,"Cytokinetics Announces Licensing Collaboration and Royalty Monetization Deals with RTW Investments Focused to CK-3773274, Next-Generation Cardiac Myosin Inhibitor",7/14/2020 1:30:10 PM
CYTK,"Cytokinetics Announces Participation in the Launch of Kainomyx, Inc. Focused to the Treatment of Parasitic Diseases",7/13/2020 1:30:10 PM
CYTK,"Cytokinetics to Host Virtual Investor & Analyst Day on July 15, 2020",7/1/2020 10:00:10 PM
CYTK,Cytokinetics to Participate In Upcoming Investor Conferences,6/8/2020 10:00:10 PM
CYTK,Cytokinetics and The ALS Association Renew Partnership to Advance the Fight Against ALS,5/27/2020 1:30:10 PM
CYTK,"AMC, CYTK, MT and SALT among midday movers",5/11/2020 4:40:05 PM
CYTK,Amgen:FDA Grants Fast Track Designation For Omecamtiv Mecarbil In Heart Failure ,5/8/2020 3:21:02 PM
CYTK,Cytokinetics to Hold Annual Meeting of Stockholders,5/7/2020 10:00:10 PM
CYTK,Cytokinetics Reports First Quarter 2020 Financial Results,5/6/2020 10:00:10 PM
CYTK,What Wall Street expects from Cytokinetics's earnings,5/5/2020 3:01:45 PM
CYTK,"Cytokinetics to Announce First Quarter Results on May 6, 2020",4/22/2020 10:00:10 PM
CYTK,Cytokinetics Provides Clinical Trials and Business Update in Response to COVID-19 Pandemic,4/14/2020 1:30:10 PM
CYTK,Evercore bearish on medical device makers in premarket analyst action,4/9/2020 11:32:59 AM
CYTK,Cytokinetics to Participate in the 19th Annual Needham Virtual Healthcare Conference,4/8/2020 10:00:10 PM
CYTK,Correction: Cytokinetics Announces Baseline Characteristics from GALACTIC-HF at ACC.20/WCC Virtual,3/30/2020 7:34:55 PM
CYTK,CYTOKINETICS TO ANNOUNCE BASELINE CHARACTERISTICS FROM GALACTIC-HF DURING ACC.20/WCC,3/20/2020 9:00:00 PM
CYTK,Cytokinetics Granted European Orphan Designation for Reldesemtiv for the Treatment of Amyotrophic Lateral Sclerosis,3/4/2020 1:30:00 PM
CYTK,Cytokinetics Reports Fourth Quarter 2019 Financial Results,3/3/2020 10:00:00 PM
CYTK,Here's what Wall Street expects from Cytokinetics's earnings,3/2/2020 3:01:32 PM
CYTK,Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day,2/28/2020 1:30:00 PM
CYTK,"Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis",2/26/2020 2:30:00 PM
CYTK,"Stock To Watch: One Down, One To Go For Cytokinetics (CYTK) ",2/24/2020 12:30:56 PM
CYTK,Cytokinetics Announces Preclinical Data for CK-3773274 Presented at the Biophysical Society 64th Annual Meeting,2/20/2020 1:30:00 PM
CYTK,"Cytokinetics to Announce Fourth Quarter Results on March 3, 2020",2/18/2020 10:00:00 PM
CYTK,"Cytokinetics Announces Publication Relating to Design of GALACTIC-HF, a Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure",2/6/2020 10:30:00 AM
CYTK,Cytokinetics Announces Recipients of Second Annual Communications Fellowship Grants,1/22/2020 1:30:00 PM
CYTK,Cytokinetics Announces Vision 2025 and Outlines 2020 Corporate Milestones,1/13/2020 1:30:00 PM
CYTK,"Cytokinetics Announces Start of Redwood-HCM, a Phase 2 Clinical Trial of CK-3773274",1/6/2020 1:30:00 PM
CYTK,Cytokinetics Granted Orphan Drug Designation for Reldesemtiv for the Treatment of Amyotrophic Lateral Sclerosis,12/18/2019 1:30:00 PM
CYTK,Cytokinetics Announces New Results Presented at the International Symposium on ALS/MND,12/5/2019 1:30:10 PM
CYTK,Cytokinetics to Participate in the Piper Jaffray Healthcare Conference,11/27/2019 10:00:10 PM
CYTK,Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND,11/26/2019 10:00:10 PM
CYTK,New Results From COSMIC-HF Presented at AHA 2019 Show Treatment of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral or Improved Measures of Diastolic Function,11/18/2019 3:00:00 PM
CYTK,Cytokinetics Announces Additional Results From COSMIC-HF to be Presented at the American Heart Association Scientific Sessions 2019,11/11/2019 3:00:00 PM
CYTK,Cytokinetics Announces Pricing of Public Offering of Convertible Senior Notes,11/8/2019 1:30:00 PM
CYTK,Cytokinetics Announces Proposed Public Offering of  Convertible Senior Notes,11/6/2019 10:05:58 PM
CYTK,Cytokinetics to Participate in the Credit Suisse 28th Annual Healthcare Conference ,11/5/2019 1:30:00 PM
CYTK,Cytokinetics Reports Third Quarter 2019 Financial Results,10/31/2019 9:00:05 PM
CYTK,"Cytokinetics to Announce Third Quarter Results on October 31, 2019",10/24/2019 10:00:05 PM
CYTK,Cytokinetics Announces Presentation of Additional Analyses From FORTITUDE-ALS at the 18th Annual NEALS Meeting,10/4/2019 1:30:00 PM
CYTK,Cytokinetics Announces Additional Results From FORTITUDE-ALS to be Presented at the 18th Annual NEALS Meeting,9/26/2019 10:00:00 PM
CYTK,Cytokinetics Announces Second Annual Communications Fellowship Program Call for Proposals,9/25/2019 1:30:00 PM
CYTK,Cytokinetics Announces Data From Phase 1 Study of CK-3773274 at the HFSA 23ʳᵈ Annual Scientific Meeting,9/16/2019 1:30:00 PM
CYTK,Cytokinetics Announces Presentations at  the 23rd Annual HFSA Scientific Meeting,9/6/2019 10:00:00 PM
CYTK,Cytokinetics to Present at September Investor Conferences,9/3/2019 10:00:00 PM
CYTK,Cytokinetics and Cure SMA Renew Partnership to Advance Education and Awareness of SMA,8/27/2019 1:30:00 PM
CYTK,Cytokinetics Reports Second Quarter 2019 Financial Results,8/8/2019 10:06:08 PM
CYTK,Here's what Wall Street expects from Cytokinetics's earnings,8/7/2019 3:03:51 PM
CYTK,Cytokinetics Announces Preclinical Data for CK-3773274 Presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions,7/31/2019 1:30:00 PM
CYTK,"Cytokinetics to Announce Second Quarter Results on August 8, 2019",7/25/2019 10:00:00 PM
CYTK,Cytokinetics Announces Publication of Preclinical Data Demonstrating Fast Skeletal Muscle Troponin Activator Improves Muscle Energetics,7/24/2019 1:30:00 PM
CYTK,Cytokinetics Granted European Orphan Designation for Reldesemtiv for the Treatment of Spinal Muscular Atrophy,7/23/2019 1:30:00 PM
CYTK,Cytokinetics Announces Preclinical Data Relating to CK-3773274 to be Presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions,7/22/2019 10:00:00 PM
CYTK,"Cytokinetics Announces Completion of Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure",7/15/2019 1:30:00 PM
CYTK,Cytokinetics Announces Preclinical Data For Reldesemtiv Presented at the 2019 Annual Cure SMA Conference,6/28/2019 1:30:00 PM
CYTK,Cytokinetics Announces Preclinical Data for Reldesemtiv to be Presented at the 2019 Annual Cure SMA Conference,6/24/2019 10:00:00 PM
CYTK,Cytokinetics to Present at the JMP Securities Life Sciences Conference,6/12/2019 10:00:00 PM
CYTK,Cytokinetics and the ALS Association Renew Partnership to Advance the Fight Against ALS,5/30/2019 1:30:00 PM
CYTK,Cytokinetics Reports First Quarter 2019 Financial Results,5/9/2019 10:00:00 PM
CYTK,Cytokinetics to Hold Annual Meeting of Stockholders,5/8/2019 10:00:00 PM
CYTK,"Cytokinetics Announces Results of FORTITUDE-ALS, a Phase 2 Clinical Trial of Reldesemtiv in Patients With ALS, Presented at American Academy of Neurology Annual Meeting",5/5/2019 7:11:00 PM
CYTK,"Cytokinetics to Announce First Quarter Results on May 9, 2019",4/25/2019 10:00:00 PM
CYTK,Cytokinetics to Present at April Investor Conferences,4/1/2019 10:00:00 PM
CYTK,"Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis",3/20/2019 1:30:00 PM
CYTK,Cytokinetics Announces Presentation of Additional Results From COSMIC-HF at ACC.19,3/18/2019 9:00:00 PM
CYTK,Cytokinetics Announces Additional Results From  COSMIC-HF to be Presented at ACC.19,3/11/2019 5:04:38 PM
CYTK,Cytokinetics Announces Presentation of Results From FORTITUDE-ALS at the American Academy of Neurology 71st Annual Meeting,3/7/2019 10:10:27 PM
CYTK,Cytokinetics Joins Global Initiative  To Recognize International Rare Disease Day,2/28/2019 1:30:00 PM
CYTK,Cytokinetics Reports Fourth Quarter 2018 Financial Results,2/21/2019 10:00:00 PM
CYTK,Cytokinetics earnings preview: what to expect,2/20/2019 3:01:33 PM
CYTK,"Cytokinetics to Announce Fourth Quarter Results on February 21, 2019",2/7/2019 10:00:00 PM
CYTK,Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients With SMA,1/22/2019 1:30:00 PM
CYTK,Cytokinetics Announces New Data Presented at the International Symposium on ALS/MND,12/10/2018 1:30:00 PM
CYTK,"Cytokinetics Announces Initiation of Phase 1 Clinical Trial of CK-3773274, a Cardiac Myosin Inhibitor",12/5/2018 1:30:00 PM
CYTK,"Cytokinetics Completes Enrollment in FORTITUDE-ALS,  Phase 2 Clinical Trial of Reldesemtiv in Patients With ALS",11/27/2018 1:30:00 PM
CYTK,Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND,11/26/2018 10:00:00 PM
CYTK,Cytokinetics to Participate in Upcoming Investor Conferences,11/7/2018 10:00:00 PM
CYTK,"Cytokinetics, Inc. Reports Third Quarter 2018 Financial Results",11/1/2018 9:00:00 PM
CYTK,Cytokinetics earnings preview: what to expect,10/31/2018 3:02:40 PM
CYTK,"Cytokinetics to Announce Third Quarter Results on November 1, 2018",10/18/2018 10:00:00 PM
CYTK,Cytokinetics Unveils Expanded Development Pipeline  and Provides Key Updates on Late-Stage Clinical  Research Programs at R&D Day,10/16/2018 1:30:00 PM
CYTK,Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program,10/5/2018 1:30:00 PM
CYTK,"Cytokinetics to Host R&D Day on October 16, 2018",10/2/2018 10:00:00 PM
CYTK,Cytokinetics to Present at the Cantor Fitzgerald Global Healthcare Conference,9/25/2018 10:00:00 PM
CYTK,"Week Ahead In Pharmaceuticals: 10 Stocks To Watch (CKPT, SNDX, ADMP...) ",9/22/2018 10:07:24 AM
CYTK,Cytokinetics to Present at the Morgan Stanley Global Healthcare Conference,9/5/2018 10:00:00 PM
CYTK,Cytokinetics Awards Inaugural Communications Fellowship To The ALS Association Golden West Chapter,8/28/2018 2:30:00 PM
CYTK,"Cytokinetics, Inc. Reports Second Quarter 2018 Financial Results",7/26/2018 10:00:00 PM
CYTK,Cytokinetics earnings preview: what to expect,7/25/2018 3:02:27 PM
CYTK,"Cytokinetics to Announce Second Quarter Results on July 26, 2018",7/12/2018 10:00:00 PM
CYTK,Cytokinetics Announces Data  From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy Presented at the 2018 Annual Cure SMA ConferenceFirst Study of Muscle-Directed...,6/16/2018 5:40:00 PM
CYTK,Cytokinetics to Present at the JMP Securities Life Sciences Conference,6/13/2018 10:00:00 PM
CYTK,"Cytokinetics Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy to be Presented at the 2018 Annual Cure SMA Conference on June 16, 2018",6/8/2018 10:00:00 PM
CYTK,Cytokinetics and Cure SMA Renew and Expand Partnership to Advance Education and Awareness of SMA,5/17/2018 1:30:00 PM
CYTK,Cytokinetics to Hold Annual Meeting of Stockholders,5/10/2018 10:00:00 PM
CYTK,Cytokinetics and the ALS Association Renew Partnership to Advance the Fight Against ALS,5/1/2018 1:30:00 PM
CYTK,"Cytokinetics, Inc. Reports First Quarter 2018 Financial Results",4/26/2018 10:00:00 PM
CYTK,Cytokinetics Announces Presentation of Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy at the 2018 Annual Cure SMA Conference,4/24/2018 1:30:00 PM
CYTK,"Cytokinetics to Announce First Quarter Results on April 26, 2018",4/12/2018 10:00:00 PM
CYTK,Cytokinetics to Present at March Investor Conferences,3/5/2018 10:00:00 PM
CYTK,Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day,2/28/2018 1:30:00 PM
CYTK,"Cytokinetics, Inc. Reports Fourth Quarter 2017 Financial Results",2/15/2018 10:00:00 PM
CYTK,Cytokinetics to Present at the RBC Capital Markets Global Healthcare Conference,2/14/2018 10:00:00 PM
CYTK,"Cytokinetics Names Robert Califf, M.D., to Board of DirectorsAppointment Strengthens Regulatory, Global Clinical Research and Cardiology Expertise as Company Advances Its Development Pipeline and...",2/12/2018 1:30:00 PM
CYTK,"Cytokinetics to Announce Fourth Quarter Results on February 15, 2018",2/2/2018 10:00:00 PM
CYTK,BRIEF-Cytokinetics Announces Progress Against Vision 2020 (CYTK),1/3/2018 1:37:03 PM
CYTK,Cytokinetics Announces Presentation of Results From VITALITY-ALS at 28th International Symposium on ALS/MND,12/8/2017 10:20:00 PM
CYTK,Cytokinetics Announces Results of VITALITY-ALS to be Presented at the International Symposium on ALS/MND,12/1/2017 10:00:00 PM
CYTK,New Publication Summarizes Phase 1 Studies of CK-2127107  Showing Tolerability and Amplification of Skeletal Muscle Response to Nerve Activation,11/30/2017 1:30:00 PM
CYTK,"APEN Gains Steam, SGRY Starting To Heal, AZRX Catches Eyes, No Stopping CPRX ",11/29/2017 3:06:36 AM
CYTK,"OSUR Turns Heads, MRSN To Report Data By Year-end, CYTK Loses Vitality ",11/22/2017 3:17:08 AM
CYTK,A treatment for ALS just failed a key clinical trial (CYTK),11/21/2017 1:42:03 PM
CYTK,Cytokinetics Announces Additional Results From COSMIC-HF at the American Heart Association Scientific Sessions 2017,11/13/2017 8:10:00 PM
CYTK,Cytokinetics Announces Additional Results From COSMIC-HF to Be Presented at the American Heart Association Scientific Sessions 2017,11/6/2017 10:20:20 PM
CYTK,"BRIEF-Cytokinetics files for potential mixed shelf, size undisclosed‍​ (CYTK)",11/3/2017 11:17:03 PM
CYTK,BRIEF-Cytokinetics reports Q3 loss of ‍$0.60/shr​ (CYTK),10/26/2017 10:12:12 PM
CYTK,"Cytokinetics to Announce Third Quarter Results on October 26, 2017",10/12/2017 10:00:00 PM
CYTK,"Cytokinetics Announces Dosing of First Patient in Japan in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart FailureCompany Earns $10 Million Milestone Payment from...",9/19/2017 1:30:00 PM
CYTK,Cytokinetics Announces Presentation of Additional Results From COSMIC-HF at the HFSA 21st Annual Scientific MeetingEffects of Omecamtiv Mecarbil Were Similar in Patients with Ischemic and...,9/18/2017 1:30:00 PM
CYTK,Cytokinetics Announces Additional Results From COSMIC-HF to be Presented at the HFSA 21st  Annual Scientific Meeting,9/11/2017 10:00:00 PM
CYTK,"Stock Performance Review on Biotech Industry -- Blueprint Medicines, Calithera Biosciences, Concordia Intl., and Cytokinetics",8/14/2017 1:10:00 PM
CYTK,"Gainers & Losers Of Aug.3: OMED, OSUR, PACB, AGRX, ELGX... ",8/4/2017 4:30:25 AM
CYTK,BRIEF-Cytokinetics Q2 loss per share $0.60 (CYTK),8/2/2017 10:37:04 PM
CYTK,BRIEF-Cytokinetics announces start of FORTITUDE-ALS (CYTK),7/27/2017 2:32:11 PM
CYTK,"BRIEF-Cytokinetics reports baseline data from first cohort of phase 2 clinical trial of ck-2127107 in patients with SMA (CYTK, 4503)",7/5/2017 1:42:03 PM
CYTK,"BRIEF-Cytokinetics says Ching Jaw joined co as senior vice president, CFO on June 26, 2017 (CYTK)",6/29/2017 10:52:03 PM
CYTK,"Daily Technical Summary Reports on Biotech Stocks -- Concordia, Cytokinetics, Dermira, and Endocyte",6/27/2017 12:50:00 PM
CYTK,BRIEF-Cytokinetics announces orphan drug designation for CK-2127107 for treatment of spinal muscular atrophy (CYTK),5/15/2017 1:50:06 PM
CYTK,"FDA Snubs TXMD, AGRX To Try Luck Again, CYTK Abuzz, ROKA Surges After-Hours ",5/9/2017 12:09:07 PM
CYTK,BRIEF-Cytokinetics announces proposed public offering of common stock (CYTK),5/8/2017 11:14:03 PM
CYTK,BRIEF-Cytokinetics Q1 loss per share $0.62 (CYTK),4/27/2017 10:11:06 PM
CYTK,Las Vegas Sands Reports First Quarter 2017 Results,4/26/2017 10:01:00 PM
CYTK,"Gainers & Losers Of Apr.18: XOMA, AKTX, CYTK, AGIO, SRNE... ",4/19/2017 5:31:00 AM
CYTK,"Gigamon, CBL & Associates Properties and Cytokinetics Set to Join S&P SmallCap 600",4/18/2017 12:20:00 AM
CYTK,BRIEF-Cytokinetics announces start of second cohort in Phase 2 clinical trial of CK-2127107 (CYTK),3/29/2017 2:14:48 PM
CYTK,BRIEF-Cytokinetics and Origent Data Sciences report advancement of research collaboration (CYTK),3/23/2017 12:56:48 PM
CYTK,BRIEF-Cytokinetics announces preclinical data for CK-2127107 presented at MDA Scientific Conference (CYTK),3/22/2017 12:56:47 PM
CYTK,BRIEF-Cytokinetics says results showed omecamtiv mecarbil improved myocardial deformation (CYTK),3/20/2017 12:56:44 PM
CYTK,BRIEF-Cytokinetics Q4 EPS $0.16 (CYTK),2/16/2017 10:20:11 PM
